Filing Details
ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:ONCY
ONCOLYTICS BIOTECH INC (ONCY) Reports Material Event to SEC
Filing Details ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context…
Market Context
ONCOLYTICS BIOTECH INC's stock currently trades at $0.85 with a market capitalization of $100.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ONCOLYTICS BIOTECH INC's stock.
All SEC filings for ONCOLYTICS BIOTECH INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ONCY Stock Page
Frequently Asked Questions
Where can I read ONCY's SEC filings?
Browse all filings on our ONCY SEC filings page.
What types of SEC filings does ONCOLYTICS BIOTECH INC file?
Public companies like ONCOLYTICS BIOTECH INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.